DrugPatentWatch Database Preview
ERGOLOID MESYLATES - Generic Drug Details
» See Plans and Pricing
What are the generic drug sources for ergoloid mesylates and what is the scope of freedom to operate?
Ergoloid mesylates
is the generic ingredient in eight branded drugs marketed by Novartis, Mutual Pharm, Sun Pharm Industries, Watson Labs, Sandoz, 3M, Bristol Myers Squibb, Kv Pharm, Lederle, Superpharm, Vangard, and Ivax Pharms, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.There are four drug master file entries for ergoloid mesylates. One supplier is listed for this compound.
Summary for ERGOLOID MESYLATES
| US Patents: | 0 |
| Tradenames: | 8 |
| Applicants: | 12 |
| NDAs: | 34 |
| Drug Master File Entries: | 4 |
| Suppliers / Packagers: | 1 |
| Clinical Trials: | 1 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for ERGOLOID MESYLATES |
| DailyMed Link: | ERGOLOID MESYLATES at DailyMed |
Recent Clinical Trials for ERGOLOID MESYLATES
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Sinphar Pharmaceutical Co., Ltd | Phase 2 |
Medical Subject Heading (MeSH) Categories for ERGOLOID MESYLATES
US Patents and Regulatory Information for ERGOLOID MESYLATES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sandoz | ALKERGOT | ergoloid mesylates | TABLET;SUBLINGUAL | 087417-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Kv Pharm | ERGOLOID MESYLATES | ergoloid mesylates | TABLET;SUBLINGUAL | 086264-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| 3m | CIRCANOL | ergoloid mesylates | TABLET;SUBLINGUAL | 084868-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Watson Labs | ERGOLOID MESYLATES | ergoloid mesylates | TABLET;SUBLINGUAL | 087183-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ERGOLOID MESYLATES
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Novartis | HYDERGINE LC | ergoloid mesylates | CAPSULE;ORAL | 018706-001 | Jan 18, 1983 | Start Trial | Start Trial |
| Novartis | HYDERGINE | ergoloid mesylates | SOLUTION;ORAL | 018418-001 | Approved Prior to Jan 1, 1982 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
